SelectQuote (NYSE:SLQT – Get Free Report) released its earnings results on Monday. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01), Zacks reports. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. SelectQuote updated its FY 2025 guidance to EPS.
SelectQuote Stock Down 10.8%
Shares of SelectQuote stock opened at $2.38 on Monday. The stock’s fifty day moving average is $3.29 and its 200-day moving average is $3.50. The firm has a market capitalization of $409.87 million, a PE ratio of -26.56 and a beta of 1.26. The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. SelectQuote has a 12-month low of $1.62 and a 12-month high of $6.86.
Analyst Ratings Changes
Separately, Noble Financial raised SelectQuote to a “strong-buy” rating in a research note on Wednesday, February 12th.
Insider Transactions at SelectQuote
In related news, insider Sarah Taylor Anderson sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $5.44, for a total transaction of $272,000.00. Following the completion of the transaction, the insider now owns 1,166 shares in the company, valued at $6,343.04. This trade represents a 97.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.40% of the stock is owned by insiders.
SelectQuote Company Profile
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Read More
- Five stocks we like better than SelectQuote
- Conference Calls and Individual Investors
- Tech Bears Should Jump on These 3 Inverse ETFs
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 5 Reasons the Rebound in Microchip Technology Stock Is Real
- How to Profit From Growth Investing
- Rocket Lab: Earnings Miss But Neutron Momentum Holds
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.